{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:29:40Z","timestamp":1787315380504,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12906-015-0579-6","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T16:04:38Z","timestamp":1425485078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics"],"prefix":"10.1186","volume":"15","author":[{"given":"Lianhong","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"579_CR1","first-page":"795","volume":"9","author":"B Desany","year":"2004","unstructured":"Desany B, Zhang ZM. Bioinformatics and cancer target discovery. Res Focus. 2004;9:795\u2013802.","journal-title":"Res Focus"},{"key":"579_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.1158140","volume":"321","author":"M Campillos","year":"2008","unstructured":"Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. Drug Target Identification Using Side-Effect Similarity. Science. 2008;321:263\u20136.","journal-title":"Science"},{"key":"579_CR3","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/bioinformatics\/btp433","volume":"25","author":"B Kevin","year":"2009","unstructured":"Kevin B, Yoshihiro Y. Supervised prediction of drug\u2013target interactions using bipartite local models. Bioinformatics. 2009;25:2397\u2013403.","journal-title":"Bioinformatics"},{"key":"579_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","volume":"261","author":"M Rarey","year":"1996","unstructured":"Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996;261:470\u201389.","journal-title":"J Mol Biol"},{"key":"579_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jmgm.2010.09.004","volume":"29","author":"HF Liu","year":"2010","unstructured":"Liu HF, Qing S, Jian Z, Wei F. Evaluation of various inverse docking schemes in multiple targets identification. J Mo Graph Model. 2010;29:326\u201330.","journal-title":"J Mo Graph Model"},{"key":"579_CR6","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.ejmech.2009.12.025","volume":"45","author":"P Tania","year":"2010","unstructured":"Tania P, Soumana OS, Pajeva I, Miteva MA. Post-docking virtual screening of diverse binding pockets: Comparative study using DOCK, AMMOS, X-Score and FRED scoring functions. Eur J Med Chem. 2010;45:2622\u20138.","journal-title":"Eur J Med Chem"},{"key":"579_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1093-3263(01)00109-7","volume":"20","author":"YZ Chen","year":"2001","unstructured":"Chen YZ, Ung CY. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J Mol Graph Model. 2001;20:199\u2013218.","journal-title":"J Mol Graph Model"},{"key":"579_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4155\/fmc.13.207","volume":"6","author":"PS Kharkar","year":"2014","unstructured":"Kharkar PS, Warrier S, Gaud RS. Reverse docking: a powerful tool for drug repositioning and drug rescue. Future Med Chem. 2014;6:333\u201342.","journal-title":"Future Med Chem"},{"key":"579_CR9","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1471-2105-13-215","volume":"13","author":"M Lee","year":"2012","unstructured":"Lee M, Kim DS. Large-scale reverse docking profiles and their applications. BMC Bioinformatics. 2012;13:S6.","journal-title":"BMC Bioinformatics"},{"key":"579_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2105-9-104","volume":"9","author":"ZT Gao","year":"2008","unstructured":"Gao ZT, Li HL, Zhang HL, Liu XF, Kang L, Luo XM, et al. PDID: a web-accessible protein database for drug target identification. BMC Bioinformatics. 2008;9:104.","journal-title":"BMC Bioinformatics"},{"key":"579_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"JK Michael","year":"2009","unstructured":"Michael JK, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462:175\u201381.","journal-title":"Nature"},{"key":"579_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxlet.2005.02.004","volume":"158","author":"N Yuri","year":"2005","unstructured":"Yuri N, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett. 2005;158:20\u20139.","journal-title":"Toxicol Lett"},{"key":"579_CR13","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.jbi.2011.04.007","volume":"44","author":"LP Paea","year":"2011","unstructured":"Paea LP, Musen MA, Shah NH. Enabling enrichment analysis with the Human Disease Ontology. J Biomed Inf. 2011;44:S31\u20138.","journal-title":"J Biomed Inf"},{"key":"579_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/00498250600861660","volume":"36","author":"S Ekins","year":"2006","unstructured":"Ekins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y. Algorithms for network analysis in system-ADME\/Tox using the MetaCore and MetaDrug platforms. Xenobiotica. 2006;36:877\u2013901.","journal-title":"Xenobiotica"},{"key":"579_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1021\/np010322w","volume":"65","author":"Q Mi","year":"2002","unstructured":"Mi Q, Lantvit D, Reyes-Lim E, Chai H, Zhao W. Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod. 2002;65:842\u201350.","journal-title":"J Nat Prod"},{"key":"579_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1248\/bpb.25.193","volume":"25","author":"J Cai","year":"2002","unstructured":"Cai J, Liu M, Wang Z, Ju Y. Apoptosis induced by dioscin in hela cells. Biol Pharm Bull. 2002;25:193\u20136.","journal-title":"Biol Pharm Bull"},{"key":"579_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4161\/cbt.13.3.18693","volume":"13","author":"Z Wang","year":"2012","unstructured":"Wang Z, Cheng Y, Wang N, Wang DM, Li YW. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol Ther. 2012;13:138\u201347.","journal-title":"Cancer Biol Ther"},{"key":"579_CR18","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.3748\/wjg.v17.i39.4389","volume":"17","author":"LL Gao","year":"2011","unstructured":"Gao LL, Li FR, Jiao P, Yang MF, Zhou XJ. Paris chinensis dioscin induces G2\/M cell cycle arrest and apoptosis in human gastric cancer SGC-7901 cells. World J Gastroenterol. 2011;17:4389\u201395.","journal-title":"World J Gastroenterol"},{"key":"579_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1055\/s-0030-1250461","volume":"77","author":"BN Lu","year":"2011","unstructured":"Lu BN, Yin L, Xu L, Peng J. Application of proteomic and bioinformatic techniques for studying the hepatoprotective effect of dioscin against CCl4-induced liver damage in mice. Planta Med. 2011;77:407\u201315.","journal-title":"Planta Med"},{"key":"579_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.toxlet.2012.08.005","volume":"214","author":"XM Zhao","year":"2012","unstructured":"Zhao XM, Cong X, Zheng L, Xu L, Yin L, Peng J. Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo. Toxico Lett. 2012;214:69\u201380.","journal-title":"Toxico Lett"},{"key":"579_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.etap.2012.03.010","volume":"34","author":"BN Lu","year":"2012","unstructured":"Lu BN, Xu Y, Xu L, Cong X, Yin L, Li H, et al. Mechanism investigation of dioscin against CCl4-induced acute liver damage in mice. Environ Toxicol Pharmaco. 2012;34:127\u201335.","journal-title":"Environ Toxicol Pharmaco"},{"key":"579_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1074-5521(03)00095-4","volume":"10","author":"SJ Haggarty","year":"2003","unstructured":"Haggarty SJ, Koeller KM, Wong JC, Butcher RA, Schreiber SL. Multidimensional chemical genetic analysis of diversityoriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem Biol. 2003;10:383\u201396.","journal-title":"Chem Biol"},{"key":"579_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/416653a","volume":"416","author":"FG Kuruvilla","year":"2002","unstructured":"Kuruvilla FG, Shamji AF, Sternson SM, Hergenrother PJ, Schreiber SL. Dissecting glucose signaling with diversity-oriented synthesis and small-molecule microarrays. Nature. 2002;416:653\u20137.","journal-title":"Nature"},{"key":"579_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jmgm.2011.01.002","volume":"29","author":"SZ Grinter","year":"2011","unstructured":"Grinter SZ, Liang YY, Huang SY, Hyder SM, Zou XQ. An inverse docking approach for identifying new potential anti-cancer targets. J Mol Graph Model. 2011;29:795\u20139.","journal-title":"J Mol Graph Model"},{"key":"579_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1078\/0171-2985-00137","volume":"205","author":"WD Alister","year":"2002","unstructured":"Alister WD. Which Came First, the Lectin\/Classical Pathway or the Alternative Pathway of Complement? Immunobiol. 2002;205:340\u201354.","journal-title":"Immunobiol"},{"key":"579_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1042\/bj1990497","volume":"199","author":"RG Discipio","year":"1981","unstructured":"Discipio RG. The conversion of human complement component C5 into fragment C5b by the alternative pathway C5 convertase. Biochem J. 1981;199:497\u2013504.","journal-title":"Biochem J"},{"key":"579_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0065-2776(08)60868-8","volume":"61","author":"MK Liszewski","year":"1996","unstructured":"Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP. Control of the complement system. Adv Immunol. 1996;61:201\u201383.","journal-title":"Adv Immunol"},{"key":"579_CR28","doi-asserted-by":"publisher","first-page":"15591","DOI":"10.1074\/jbc.272.25.15591","volume":"272","author":"PF Lebowitz","year":"1997","unstructured":"Lebowitz PF, Casey PJ, Prendergast GC, Thissen JA. Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. J boil Chem. 1997;272:15591\u20134.","journal-title":"J boil Chem"},{"key":"579_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0005-2728(99)00016-X","volume":"1411","author":"DJ Stuehr","year":"1999","unstructured":"Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta. 1999;1411:217\u201330.","journal-title":"Biochim Biophys Acta"},{"key":"579_CR30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.fertnstert.2009.04.020","volume":"94","author":"M Al-Azemi","year":"2010","unstructured":"Al-Azemi M, Refaat B, Amer S, Ola B, Chapman N, Ledger W. The expression of inducible nitric oxide synthase in the human fallopian tube during the menstrual cycle and in ectopic pregnancy. Fertil Steril. 2010;94:833\u201340.","journal-title":"Fertil Steril"},{"key":"579_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1359-6446(05)03420-3","volume":"10","author":"N Yuri","year":"2005","unstructured":"Yuri N, Nikolskaya T, Bugrim A. Biological networks and analysis of experimental data in drug discovery. Drug Discov Today. 2005;10:653\u201362.","journal-title":"Drug Discov Today"},{"key":"579_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S1357-2725(02)00305-9","volume":"35","author":"M Merja","year":"2003","unstructured":"Merja M, J\u00e4rvinen K, Hotti A, Okkeri J, Laitinen J. Transcriptional regulation of the ornithine decarboxylase gene by c-Myc\/Max\/Mad network and retinoblastoma protein interacting with c-Myc. Inter J Biochem Cell Biol. 2003;35:496\u2013521.","journal-title":"Inter J Biochem Cell Biol"},{"key":"579_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molonc.2012.04.003","volume":"6","author":"AV Laenkholm","year":"2012","unstructured":"Laenkholm AV, Knoop A, Ejlertsen B, Rudbeck T, Jensen MB. ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry. Mol Oncol. 2012;6:428\u201336.","journal-title":"Mol Oncol"},{"key":"579_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tiv.2012.10.001","volume":"27","author":"CY Hsieh","year":"2013","unstructured":"Hsieh CY, Tsai PC, Tseng CH, Chen YL, Chang LS, Lin SR. Inhibition of EGF\/EGFR activation with naphtho [1,2-b] furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells. Toxicol In Vitro. 2013;27:1\u201310.","journal-title":"Toxicol In Vitro"},{"key":"579_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bcp.2012.06.025","volume":"84","author":"YT Chen","year":"2012","unstructured":"Chen YT, Shi D, Yang D, Yan B. Antioxidant sulforaphane and sensitizer trinitrobenzene sulfonate induce carboxylesterase-1 through a novel element transactivated by nuclear factor-E2 related factor-2. Biochem Pharmacol. 2012;84:864\u201371.","journal-title":"Biochem Pharmacol"},{"key":"579_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1101\/sqb.2010.75.028","volume":"75","author":"LE Maquat","year":"2010","unstructured":"Maquat LE, Hwang J, Sato H, Tang Y. CBP80-promoted mRNP rearrangements during the pioneer round of translation, nonsense-mediated mRNA decay, and thereafter. Cold Spring Harb Symp Quant Biol. 2010;75:127\u201334.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"579_CR37","doi-asserted-by":"publisher","first-page":"e47638","DOI":"10.1371\/journal.pone.0047638","volume":"7","author":"TK Koch","year":"2012","unstructured":"Koch TK, Reuter M, Barthel D, B\u00f6hm S, van den Elsen J. Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b. PLoS One. 2012;7:e47638.","journal-title":"PLoS One"},{"key":"579_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0169-328X(02)00460-6","volume":"108","author":"C Sang","year":"2012","unstructured":"Sang C, Kobayashi Y, Du J, Katsumo M, Adachi H. c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line. Mol Brain Res. 2012;108:7\u201317.","journal-title":"Mol Brain Res"},{"key":"579_CR39","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.nut.2012.02.006","volume":"28","author":"J Fan","year":"2012","unstructured":"Fan J, Li X, Yan YW, Tian XH, Hou WJ. Curcumin attenuates rat thoracic aortic aneurysm formation by inhibition of the c-Jun N-terminal kinase pathway and apoptosis. Nutrition. 2012;28:1068\u201374.","journal-title":"Nutrition"},{"key":"579_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.neuroscience.2011.04.070","volume":"189","author":"LL Wang","year":"2011","unstructured":"Wang LL, Zhao XC, Yan LF, Wang YQ, Cheng X. C-Jun phosphorylation contributes to down regulation of neuronal nitric oxide synthase protein and motoneurons death in injured spinal cords following root-avulsion of the brachial plexus. Neurosci. 2011;189:397\u2013407.","journal-title":"Neurosci"},{"key":"579_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cbi.2006.05.009","volume":"162","author":"SB Su","year":"2006","unstructured":"Su SB, Adikesavan AK, Jaiswal AK. Si RNA inhibition of GRP58 associated with decrease in mitomycin C-induced DNA cross-linking and cytotoxicity. Chem Biol Interact. 2006;162:81\u20137.","journal-title":"Chem Biol Interact"},{"key":"579_CR42","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.biocel.2008.05.003","volume":"40","author":"WL Zhang","year":"2008","unstructured":"Zhang WL, Jones VC, Scherman MS, Mahapatra S, Crick D. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase. Int J Biochem Cell Biol. 2008;40:2560\u201371.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-015-0579-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0579-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:44:39Z","timestamp":1630557879000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-015-0579-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1186\/s12906-015-0579-6","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]},"assertion":[{"value":"10 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}